跳至主要内容
临床试验/JPRN-UMIN000024726
JPRN-UMIN000024726尚未招募未知

Examination about the curative effect of Mirtazapine for the QOL of the pulmonary tumor patient. - Examination about the curative effect of Mirtazapine for the QOL of the pulmonary tumor patient.

Kyoto Prefectural University of Medicine0 个研究点目标入组 43 人开始时间: 2017年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
43

研究概览

简要总结

The results showed that patients with depression reported a worse quality of life than those without depression. Compared with no medication, the administration of mirtazapine alleviated depressive symptoms. Furthermore, the patients depressive status was affected by their physical symptoms, including coughing, tightness of chest, and dyspnea.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • The patient who could not carry out HADS or was refused. The patient who has a history of the past with hypersensitivity for mirtazapine. The patient with a history of the past with brain disorder (including dementia and Parkinson's disease) of the tissue except the metastasis to brain. The patient with the past of Mental disease medicine treatment except the sleep inducing drug within three months. The patient with severe hepatic dysfunction or renal dysfunction. The patients with the past of suicide consideration or suicide project. The patients who receive medical treatment with heart trouble (myocardial infarction, angina, conduction disorder). The patient with glaucoma or the intraocular pressure sthenia. The patients who receive medical treatment with dysuria. During a pregnant woman, the nursing and the patient who may be pregnant. The patient who takes a monoamine oxidase inhibitor (MAOI) within two weeks. The patient who judged that the examination medical attendant was inappropriate.

研究者

相似试验